• EVX-04 is successfully expressed and secreted in human cells enabling immune recognition and activation
• The vaccine antigens drive specific immune responses across different human immune profiles and induce targeted cell-killing
• Poster presentation at the European Hematology Association (EHA) 2026 Congress, taking place in Stockholm, Sweden

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.